News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Roche buys PathAI for $1.05B to scale digital pathology AI
Swiss pharma giant acquires Boston AI firm to combine digital pathology tools with oncology diagnostics globally.
Entrada stock drops 50% on weak Duchenne trial data
Biotech's Phase 1/2 Duchenne muscular dystrophy study results fell short of analyst expectations despite company claims of success.
Angelini pays $4.1B for Catalyst's rare neuro drug portfolio
Italian pharma buys US biotech with $589M revenue run rate from three CNS medicines, gaining direct access to American market.
Amgen adds $300M to Puerto Rico biologics production
The biotech giant expands its Juncos facility investment as manufacturing shifts continue across the sector.
Entrada Duchenne drug data disappoints in six patients
Biotech's exon 44 skipping therapy shows initial results in low-dose cohort, sending shares lower on investor concerns.
Blackstone backs Anagram with $250M for cystic fibrosis treatment
Private equity giant commits to biotech developing therapy for CF complication affecting thousands of patients annually.
Health insurers cut 2025 profit forecasts amid rising medical costs
Multiple major health insurance companies withdrew or reduced earnings guidance as medical expense claims exceeded expectations.
EnGene shares fall 80% on Phase 2 bladder cancer trial data
Canadian biotech's experimental bladder cancer therapy shows concerning Phase 2 results, triggering massive investor selloff Thursday morning.
NVIDIA adds Prometheus monitoring to NCCL Inspector for real-time debugging
NCCL 2.30 introduces live performance monitoring that eliminates storage overhead and enables Grafana dashboards for GPU communication debugging.
vLLM V1 migration required four fixes to match V0 RL training
ServiceNow found vLLM V1's default logprob handling, caching, and precision settings broke reinforcement learning training dynamics versus V0.
AlphaEvolve cuts DNA errors 30%, speeds TPU design in year two
DeepMind's coding agent delivered measurable wins across genomics, quantum circuits, and chip design, with commercial customers reporting 4x speedups.
OpenAI gives $10K grants to 26 college seniors who built with AI
The ChatGPT Futures program awards students from 20+ universities for using AI to create study tools, translate resources, and advance research projects.